CLINICAL DEVELOPMENT OF PI3K/AKT/MTOR INHIBITORS

Toxicity and metabolic aspects

P. Bedard

Toxicity and metabolic aspects

P. Bedard

Please set the zoomlevel of your browser to 100%.